Relief Therapeutics Holding AG
Symbool: 0QKQ.L
LSE
1.2
CHFMarktprijs vandaag
-0.1533
Koers/Winst Verhouding
-0.0017
Koers/Winst Groei Verhouding
14.91M
MRK Kapitalisatie
- 0.00%
DIV Rendement
Relief Therapeutics Holding AG (0QKQ-L) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 14.6 | 19.2 | 44.8 | |||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.net-receivables | 0 | 2.8 | 2.3 | 2.7 | |||||||||
balance-sheet.row.inventory | 0 | 0.6 | 0.2 | 0.4 | |||||||||
balance-sheet.row.other-current-assets | 0 | 0.4 | 0.9 | 7.1 | |||||||||
balance-sheet.row.total-current-assets | 0 | 18.3 | 22.6 | 55 | |||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 3 | 2.7 | 2.5 | |||||||||
balance-sheet.row.goodwill | 0 | 0.5 | 7 | 8.7 | |||||||||
balance-sheet.row.intangible-assets | 0 | 54.4 | 162.9 | 192.3 | |||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 54.4 | 169.9 | 201 | |||||||||
balance-sheet.row.long-term-investments | 0 | 53.9 | -7 | -8.7 | |||||||||
balance-sheet.row.tax-assets | 0 | 0.6 | 0.5 | 1.7 | |||||||||
balance-sheet.row.other-non-current-assets | 0 | -53.8 | 0.1 | 0.1 | |||||||||
balance-sheet.row.total-non-current-assets | 0 | 58.1 | 166.2 | 196.6 | |||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-assets | 0 | 76.4 | 188.8 | 251.6 | |||||||||
balance-sheet.row.account-payables | 0 | 1 | 1.6 | 1.7 | |||||||||
balance-sheet.row.short-term-debt | 0 | 2.2 | 2.1 | 1.7 | |||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0.3 | 0.5 | |||||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0 | 0.4 | |||||||||
Deferred Revenue Non Current | 0 | 2.1 | 2.2 | 2.2 | |||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||
balance-sheet.row.other-current-liab | 0 | 3.6 | 6.2 | 15.9 | |||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 17.3 | 32.7 | 50.4 | |||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.capital-lease-obligations | 0 | 2.1 | 2.2 | 2.2 | |||||||||
balance-sheet.row.total-liab | 0 | 24.2 | 43.4 | 70.1 | |||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.common-stock | 0 | 56.2 | 56.2 | 44.1 | |||||||||
balance-sheet.row.retained-earnings | 0 | -218.3 | -119.6 | -69.8 | |||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 6.2 | 5.3 | 2.6 | |||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 208.2 | 203.6 | 204.5 | |||||||||
balance-sheet.row.total-stockholders-equity | 0 | 52.2 | 145.4 | 181.5 | |||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 76.4 | 188.8 | 251.6 | |||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-equity | 0 | 52.2 | 145.4 | 181.5 | |||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||
Total Investments | 0 | 53.9 | -7 | -8.7 | |||||||||
balance-sheet.row.total-debt | 0 | 4.3 | 4.3 | 4.3 | |||||||||
balance-sheet.row.net-debt | 0 | -10.2 | -14.9 | -40.5 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -50.8 | -34.7 | -7.8 | ||||||||
cash-flows.row.depreciation-and-amortization | 0 | 3.9 | 2 | 0.1 | ||||||||
cash-flows.row.deferred-income-tax | 0 | -3.5 | -0.8 | 1.6 | ||||||||
cash-flows.row.stock-based-compensation | 0 | 2.2 | 1.1 | 1 | ||||||||
cash-flows.row.change-in-working-capital | 0 | 5.6 | -5.2 | 0 | ||||||||
cash-flows.row.account-receivables | 0 | 0 | -0.2 | 0 | ||||||||
cash-flows.row.inventory | 0 | 0.2 | -0.1 | 0 | ||||||||
cash-flows.row.account-payables | 0 | -0.1 | -0.8 | 1.2 | ||||||||
cash-flows.row.other-working-capital | 0 | 5.5 | -4.1 | -1.2 | ||||||||
cash-flows.row.other-non-cash-items | 0 | 18.6 | 1.9 | -13.1 | ||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -0.5 | -13.7 | 0 | ||||||||
cash-flows.row.acquisitions-net | 0 | -7.9 | -16.7 | 0 | ||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0.5 | 0.1 | 3.3 | ||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | -0.2 | ||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -8 | -30.3 | 3 | ||||||||
cash-flows.row.debt-repayment | 0 | -0.1 | -5.6 | -0.5 | ||||||||
cash-flows.row.common-stock-issued | 0 | 7.1 | 76.1 | 58.3 | ||||||||
cash-flows.row.common-stock-repurchased | 0 | -0.2 | -2.8 | -0.6 | ||||||||
cash-flows.row.dividends-paid | 0 | -6.8 | -67.7 | -58.2 | ||||||||
cash-flows.row.other-financing-activites | 0 | 6.4 | 67.7 | 58.2 | ||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 6.4 | 67.7 | 58.2 | ||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0.2 | -0.1 | 0.1 | ||||||||
cash-flows.row.net-change-in-cash | 0 | -25.5 | 1.6 | 43 | ||||||||
cash-flows.row.cash-at-end-of-period | 0 | 19.2 | 44.8 | 43.2 | ||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 44.8 | 43.2 | 0.1 | ||||||||
cash-flows.row.operating-cash-flow | 0 | -24.1 | -35.7 | -18.2 | ||||||||
cash-flows.row.capital-expenditure | 0 | -0.5 | -13.7 | 0 | ||||||||
cash-flows.row.free-cash-flow | 0 | -24.6 | -49.4 | -18.2 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 6 | 6.1 | 3.3 | |||||||||
income-statement-row.row.cost-of-revenue | 0 | 16.9 | 18.1 | 11.9 | |||||||||
income-statement-row.row.gross-profit | 0 | -10.9 | -12 | -8.6 | |||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||
income-statement-row.row.other-expenses | 0 | -0.2 | -1.3 | -0.7 | |||||||||
income-statement-row.row.operating-expenses | 0 | 9 | 24.5 | 26.6 | |||||||||
income-statement-row.row.cost-and-expenses | 0 | 25.9 | 42.6 | 38.5 | |||||||||
income-statement-row.row.interest-income | 0 | 0.1 | 0 | 0 | |||||||||
income-statement-row.row.interest-expense | 0 | 0.2 | 0.2 | 0.3 | |||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -91.8 | -17.8 | -0.3 | |||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||
income-statement-row.row.other-operating-expenses | 0 | -0.2 | -1.3 | -0.7 | |||||||||
income-statement-row.row.total-operating-expenses | 0 | -91.8 | -17.8 | -0.3 | |||||||||
income-statement-row.row.interest-expense | 0 | 0.2 | 0.2 | 0.3 | |||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 3.3 | 3.9 | 2 | |||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||
income-statement-row.row.operating-income | 0 | -19.9 | -36.5 | -35.2 | |||||||||
income-statement-row.row.income-before-tax | 0 | -111.7 | -54.3 | -35.5 | |||||||||
income-statement-row.row.income-tax-expense | 0 | -13.5 | -3.5 | -0.8 | |||||||||
income-statement-row.row.net-income | 0 | -98.2 | -50.8 | -34.7 |
Vaak gestelde vragen
Wat is Relief Therapeutics Holding AG (0QKQ.L) totale activa?
Relief Therapeutics Holding AG (0QKQ.L) totale activa is 76390000.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is N/A.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is -1.800.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is -16.274.
Wat is de totale omzet van de onderneming?
De totale opbrengst is -3.299.
Wat is Relief Therapeutics Holding AG (0QKQ.L) nettowinst (netto-inkomen)?
De nettowinst is -98181000.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 4311000.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 9045000.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 0.000.